NEW YORK, NY / ACCESSWIRE / September 28, 2017 / Large-cap and small-cap stocks soared to new intra-day records Wednesday as financial stocks surged after Republicans released details on tax reform. The Dow Jones Industrial Average gained 0.25 percent to close at 22,340.71, while the S&P 500 Index rose 0.41 percent to close at 2,507.04. The Russell 2000 Index hit an intraday record 1,487.95 before settling to close at 1,484.78, an increase of 1.92 percent. The tech-heavy NASDAQ Composite Index spiked 1.15 percent to close at 6,453.26.

"The year is going to be marked by the constant tug and war between hope of fiscal stimulus and the reality of monetary policy," said Peter Boockvar, chief market analyst at The Lindsey Group.

"There's a lot of optimism about tax reform, especially among small-caps, which stand to benefit more if this is enacted," said Michael O'Rourke, chief market strategist at JonesTrading. "There's also been some additional rotation into the parts of the market that have been doing well."

RDI Initiates Coverage on:

Finisar Corporation
https://rdinvesting.com/news/?ticker=FNSR

Sarepta Therapeutics Inc.
https://rdinvesting.com/news/?ticker=SRPT

Finisar Corporation's stock jumped 5.27% Wednesday, to close the day at $21.98. The stock recorded a trading volume of 3,711,648 shares, which was above its three months average volume of 2,868,650 shares. In the last year Finisar Corporation's shares have traded in a range of 20.16 - 36.85. The stock is currently trading 40.35% below its 52 week high. The company's shares are currently trading below their 200-day moving average. Moreover, the stock's 50-day moving average of $23.65 is below its 200-day moving average of $25.48. Shares of the company are trading at a Price to Earnings ratio of 10.34. Shares of Finisar have fallen approximately 27.39 percent year-to-date.

Access RDI's Finisar Corporation Research Report at:
https://rdinvesting.com/news/?ticker=FNSR

On Wednesday, shares of Sarepta Therapeutics Inc. recorded a trading volume of 1,783,347 shares, which was below the three months average volume of 2,619,850 shares. The stock ended the day 5.10% higher at 46.60. The share price has gained 77.46% from its 52 week low with a 52 week trading range of 26.26 - 63.73.The company's shares are currently trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $40.10 is greater than its 200-day moving average of $34.92. Shares of Sarepta Therapeutics have gained approximately 69.89 percent year-to-date.

Access RDI's Sarepta Therapeutics Inc. Research Report at:
https://rdinvesting.com/news/?ticker=SRPT

Our Actionable Research on Finisar Corporation (NASDAQ:FNSR) and Sarepta Therapeutics Inc. (NASDAQ:SRPT) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com